-
1
-
-
35548942272
-
Prevalence of resistance to nevirapine in mothers and children after singledose exposure to prevent vertical transmission of HIV-1: A meta-analysis
-
Ghent Group on HIV in Women and Children
-
Arrivé E, Newell ML, Ekouevi DK, et al; Ghent Group on HIV in Women and Children. Prevalence of resistance to nevirapine in mothers and children after singledose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007;36(5):1009-1021.
-
(2007)
Int J Epidemiol
, vol.36
, Issue.5
, pp. 1009-1021
-
-
Arrivé, E.1
Newell, M.L.2
Ekouevi, D.K.3
-
2
-
-
33847169926
-
Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine
-
Martinson NA, Morris L, Gray G, et al. Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine. J Acquir Immune Defic Syndr. 2007;44(2):148-153.
-
(2007)
J Acquir Immune Defic Syndr
, vol.44
, Issue.2
, pp. 148-153
-
-
Martinson, N.A.1
Morris, L.2
Gray, G.3
-
3
-
-
33846156885
-
Response to antiretroviral therapy after a single, peripartum dose of nevirapine
-
Lockman S, Shapiro RL, Smeaton LM, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med. 2007; 356(2):135-147.
-
(2007)
N Engl J Med
, vol.356
, Issue.2
, pp. 135-147
-
-
Lockman, S.1
Shapiro, R.L.2
Smeaton, L.M.3
-
4
-
-
77956868267
-
Nevirapine (NVP) vs lopinavir-ritonavir (LPV/r)-based antiretroviral therapy (ART) in single dose nevirapine (sdNVP)-exposed HIV-infected infants: Preliminary results from the IMPAACT P1060 trial
-
Palumbo P, Violari A, Lindsey J, et al. Nevirapine (NVP) vs lopinavir-ritonavir (LPV/r)-based antiretroviral therapy (ART) in single dose nevirapine (sdNVP)-exposed HIV-infected infants: preliminary results from the IMPAACT P1060 trial. 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa.
-
5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; July 19-22, 2009; Cape Town, South Africa
-
-
Palumbo, P.1
Violari, A.2
Lindsey, J.3
-
5
-
-
77649123118
-
Lopinavir /ritonavir+tenofovir/emtricitabine is superior to nevirapine+tenofovir/emtricitabine for women with prior exposure to single-dose nevirapine
-
A5208/OCTANE Study Team.
-
Lockman S; A5208/OCTANE Study Team. Lopinavir /ritonavir+tenofovir/ emtricitabine is superior to nevirapine+tenofovir/emtricitabine for women with prior exposure to single-dose nevirapine. 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada.
-
16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada
-
-
Lockman, S.1
-
7
-
-
51949105562
-
Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: A prospective cohort study
-
Davies MA, Boulle A, Fakir T, Nuttall J, Eley B. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatr. 2008;8:34.
-
(2008)
BMC Pediatr
, vol.8
, pp. 34
-
-
Davies, M.A.1
Boulle, A.2
Fakir, T.3
Nuttall, J.4
Eley, B.5
-
8
-
-
34249888233
-
Adherence to antiretroviral therapy for pediatric HIV infection: A qualitative systematic review with recommendations for research and clinical management
-
DOI 10.1542/peds.2006-1232
-
Simoni JM, Montgomery A, Martin E, New M, Demas PA, Rana S. Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management. Pediatrics. 2007;119(6):e1371-e1383. (Pubitemid 46871324)
-
(2007)
Pediatrics
, vol.119
, Issue.6
-
-
Simoni, J.M.1
Montgomery, A.2
Martin, E.3
New, M.4
Demas, P.A.5
Rana, S.6
-
9
-
-
41149107340
-
Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis
-
Ren Y, Nuttall JJ, Egbers C, et al. Effect of rifampicin on lopinavir pharmacokinetics in HIV-infected children with tuberculosis. J Acquir Immune Defic Syndr. 2008;47(5):566-569.
-
(2008)
J Acquir Immune Defic Syndr
, vol.47
, Issue.5
, pp. 566-569
-
-
Ren, Y.1
Nuttall, J.J.2
Egbers, C.3
-
10
-
-
4444315072
-
Metabolic complications of HIV therapy in children
-
DOI 10.1097/00002030-200409030-00004
-
McComsey GA, Leonard E. Metabolic complications of HIV therapy in children. AIDS. 2004;18 (13):1753-1768. (Pubitemid 39179627)
-
(2004)
AIDS
, vol.18
, Issue.13
, pp. 1753-1768
-
-
McComsey, G.A.1
Leonard, E.2
-
11
-
-
0037999058
-
Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children
-
Bitnun A, Sochett E, Babyn P, et al. Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children. AIDS. 2003;17(9):1319-1327.
-
(2003)
AIDS
, vol.17
, Issue.9
, pp. 1319-1327
-
-
Bitnun, A.1
Sochett, E.2
Babyn, P.3
-
12
-
-
15044343044
-
Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C
-
Pediatric AIDS Clinical Trials Group Study 219C Team
-
Farley J, Gona P, Crain M, et al; Pediatric AIDS Clinical Trials Group Study 219C Team. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C. J Acquir Immune Defic Syndr. 2005;38(4):480-487.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, Issue.4
, pp. 480-487
-
-
Farley, J.1
Gona, P.2
Crain, M.3
-
13
-
-
67651083739
-
Immune reconstitution inflammatory syndrome among HIVinfected South African infants initiating antiretroviral therapy
-
Smith K, Kuhn L, Coovadia A, et al. Immune reconstitution inflammatory syndrome among HIVinfected South African infants initiating antiretroviral therapy. AIDS. 2009;23(9):1097-1107.
-
(2009)
AIDS
, vol.23
, Issue.9
, pp. 1097-1107
-
-
Smith, K.1
Kuhn, L.2
Coovadia, A.3
-
14
-
-
77950190296
-
Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: Effect of cotreatment for tuberculosis
-
Reitz C, Coovadia A, Ko S, et al. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. J Infect Dis. 2010;201(8):1121-1131.
-
(2010)
J Infect Dis
, vol.201
, Issue.8
, pp. 1121-1131
-
-
Reitz, C.1
Coovadia, A.2
Ko, S.3
-
17
-
-
33748642352
-
Less than 95% adherence to non-nucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression
-
Bangsberg DR. Less than 95% adherence to non-nucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006; 43(7):939-941.
-
(2006)
Clin Infect Dis
, vol.43
, Issue.7
, pp. 939-941
-
-
Bangsberg, D.R.1
-
18
-
-
45749155787
-
Antiretroviral drug resistance surveillance among drug-naive HIV- 1-infected individuals in Gauteng Province, South Africa in 2002 and 2004
-
Pillay V, Ledwaba J, Hunt G, et al. Antiretroviral drug resistance surveillance among drug-naive HIV- 1-infected individuals in Gauteng Province, South Africa in 2002 and 2004. Antivir Ther. 2008;13(suppl 2): 101-107.
-
(2008)
Antivir Ther
, vol.13
, Issue.SUPPL. 2
, pp. 101-107
-
-
Pillay, V.1
Ledwaba, J.2
Hunt, G.3
-
19
-
-
77956835429
-
Development of drug resistance among a cohort of HIV-infected infants exposed to nevirapine for prevention of mother-to-child transmission initiating PI-based ART in South Africa
-
[abstract 957]
-
Hunt G, Taylor B, Coovadia A, et al. Development of drug resistance among a cohort of HIV-infected infants exposed to nevirapine for prevention of mother-to-child transmission initiating PI-based ART in South Africa [abstract 957]. 16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada.
-
16th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2009; Montreal, Canada
-
-
Hunt, G.1
Taylor, B.2
Coovadia, A.3
-
20
-
-
77956806036
-
Plasma frequencies of nevirapine resistance influence virologic responses to nevirapine maintenance therapy in single-dose exposed HIV-infected children initially treated with lopinavir HAART
-
[abstract 159]
-
Moorthy A, Kuhn L, Coovadia A, et al. Plasma frequencies of nevirapine resistance influence virologic responses to nevirapine maintenance therapy in single-dose exposed HIV-infected children initially treated with lopinavir HAART [abstract 159]. 17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, CA.
-
17th Conference on Retroviruses and Opportunistic Infections; February 16-19, 2010; San Francisco, CA
-
-
Moorthy, A.1
Kuhn, L.2
Coovadia, A.3
-
21
-
-
48949097660
-
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel
-
International AIDS Society-USA.
-
Hammer SM, Eron JJ Jr, Reiss P, et al; International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA. 2008; 300(5):555-570.
-
(2008)
JAMA
, vol.300
, Issue.5
, pp. 555-570
-
-
Hammer, S.M.1
Eron Jr., J.J.2
Reiss, P.3
-
24
-
-
1642294551
-
Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients
-
Bucher HC, Kofler A, Nüesch R, Young J, Battegay M, Opravil M. Meta-analysis of randomized controlled trials of simplified versus continued protease inhibitor-based antiretroviral therapy in HIV-1-infected patients. AIDS. 2003;17(17):2451-2459.
-
(2003)
AIDS
, vol.17
, Issue.17
, pp. 2451-2459
-
-
Bucher, H.C.1
Kofler, A.2
Nüesch, R.3
Young, J.4
Battegay, M.5
Opravil, M.6
-
25
-
-
0036258816
-
Switch studies: A review
-
Murphy RL, Smith WJ. Switch studies: a review. HIV Med. 2002;3(2):146-155.
-
(2002)
HIV Med
, vol.3
, Issue.2
, pp. 146-155
-
-
Murphy, R.L.1
Smith, W.J.2
-
26
-
-
33748042284
-
Benefits and concerns of simplification strategies in HIV-infected patients
-
DOI 10.1093/jac/dkl191
-
Negredo E, Bonjoch A, Clotet B. Benefits and concerns of simplification strategies in HIV-infected patients. J Antimicrob Chemother. 2006;58(2): 235-242. (Pubitemid 44294932)
-
(2006)
Journal of Antimicrobial Chemotherapy
, vol.58
, Issue.2
, pp. 235-242
-
-
Negredo, E.1
Bonjoch, A.2
Clotet, B.3
-
27
-
-
54049090424
-
Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: A meta-analysis of randomized controlled trials
-
Ena J, Leach A, Nguyen P. Switching from suppressive protease inhibitor-based regimens to nevirapine-based regimens: a meta-analysis of randomized controlled trials. HIV Med. 2008;9(9): 747-756.
-
(2008)
HIV Med
, vol.9
, Issue.9
, pp. 747-756
-
-
Ena, J.1
Leach, A.2
Nguyen, P.3
-
28
-
-
0042387870
-
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection
-
Nevirapine, Efavirenz, and Abacavir (NEFA) Study Team.
-
Martínez E, Arnaiz JA, Podzamczer D, et al; Nevirapine, Efavirenz, and Abacavir (NEFA) Study Team. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection. N Engl J Med. 2003; 349(11):1036-1046.
-
(2003)
N Engl J Med
, vol.349
, Issue.11
, pp. 1036-1046
-
-
Martínez, E.1
Arnaiz, J.A.2
Podzamczer, D.3
-
29
-
-
0034458546
-
Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA
-
Raffi F, Bonnet B, Ferré V, et al. Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA. Clin Infect Dis. 2000;31(5):1274-1278.
-
(2000)
Clin Infect Dis
, vol.31
, Issue.5
, pp. 1274-1278
-
-
Raffi, F.1
Bonnet, B.2
Ferré, V.3
-
30
-
-
0035393524
-
Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study
-
Spanish Lipodystrophy Group
-
Ruiz L, Negredo E, Domingo P, et al; Spanish Lipodystrophy Group. Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study. J Acquir Immune Defic Syndr. 2001;27(3):229-236.
-
(2001)
J Acquir Immune Defic Syndr
, vol.27
, Issue.3
, pp. 229-236
-
-
Ruiz, L.1
Negredo, E.2
Domingo, P.3
-
31
-
-
0037082965
-
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression
-
Negredo E, Cruz L, Paredes R, et al. Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression. Clin Infect Dis. 2002; 34(4):504-510.
-
(2002)
Clin Infect Dis
, vol.34
, Issue.4
, pp. 504-510
-
-
Negredo, E.1
Cruz, L.2
Paredes, R.3
-
32
-
-
0038121117
-
First Pediatric Switch Study. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: Results of the First Pediatric Switch Study
-
McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A; First Pediatric Switch Study. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study. Pediatrics. 2003;111(3):e275-e281.
-
(2003)
Pediatrics
, vol.111
, Issue.3
-
-
McComsey, G.1
Bhumbra, N.2
Ma, J.F.3
Rathore, M.4
Alvarez, A.5
-
33
-
-
56649086855
-
Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children
-
Gonzalez-Tome MI, Amador JT, Peña MJ, Gomez ML, Conejo PR, Fontelos PM. Outcome of protease inhibitor substitution with nevirapine in HIV-1 infected children. BMC Infect Dis. 2008;8:144.
-
(2008)
BMC Infect Dis
, vol.8
, pp. 144
-
-
Gonzalez-Tome, M.I.1
Amador, J.T.2
Peña, M.J.3
Gomez, M.L.4
Conejo, P.R.5
Fontelos, P.M.6
-
34
-
-
34247552198
-
Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
-
Chi BH, Sinkala M, Stringer EM, et al. Early clinical and immune response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine. AIDS. 2007;21(8):957-964.
-
(2007)
AIDS
, vol.21
, Issue.8
, pp. 957-964
-
-
Chi, B.H.1
Sinkala, M.2
Stringer, E.M.3
-
35
-
-
58749088735
-
Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to non-nucleoside reverse-transcriptase inhibitor-based therapy
-
Coovadia A, Hunt G, Abrams EJ, et al. Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to non-nucleoside reverse-transcriptase inhibitor-based therapy. Clin Infect Dis. 2009;48(4):462-472.
-
(2009)
Clin Infect Dis
, vol.48
, Issue.4
, pp. 462-472
-
-
Coovadia, A.1
Hunt, G.2
Abrams, E.J.3
-
36
-
-
69549103398
-
Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia
-
Kuhn L, Semrau K, Ramachandran S, et al. Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2009;52(1):132-136.
-
(2009)
J Acquir Immune Defic Syndr
, vol.52
, Issue.1
, pp. 132-136
-
-
Kuhn, L.1
Semrau, K.2
Ramachandran, S.3
-
37
-
-
34447283563
-
Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and below
-
Verweel G, Burger DM, Sheehan NL, et al. Plasma concentrations of the HIV-protease inhibitor lopinavir are suboptimal in children aged 2 years and below. Antivir Ther. 2007;12(4):453-458. (Pubitemid 47044809)
-
(2007)
Antiviral Therapy
, vol.12
, Issue.4
, pp. 453-458
-
-
Verweel, G.1
Burger, D.M.2
Sheehan, N.L.3
Bergshoeff, A.S.4
Warris, A.5
Van Der Knaap, L.C.6
Driessen, G.7
De Groot, R.8
Hartwig, N.G.9
-
38
-
-
56749097184
-
Early antiretroviral therapy and mortality among HIV-infected infants
-
CHER Study Team
-
Violari A, Cotton MF, Gibb DM, et al; CHER Study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359 (21):2233-2244.
-
(2008)
N Engl J Med
, vol.359
, Issue.21
, pp. 2233-2244
-
-
Violari, A.1
Cotton, M.F.2
Gibb, D.M.3
-
39
-
-
0003487632
-
-
Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children. Accessed August 11, 2010
-
Guidelines for the use of antiretroviral agents in pediatric HIV infection. Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children. http://aidsinfo.nih.gov/contentFiles/PediatricGuidelines. pdf. Accessed August 11, 2010.
-
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
-
-
|